VSTM

Quote

Short

News

Articles

Message Board

Verastem Inc. (NASDAQ : VSTM ) News

Verastem Inc. (NASDAQ: VSTM) News Releases

VSTM News Releases

June 03, 2026 04:01:00 pm

Business Wire

Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class Investigational KRAS G12D (ON/OFF) Inhibitor for the Treatment of KRAS G12D-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

May 27, 2026 07:30:00 am

Business Wire

Verastem Oncology to Present at Jefferies Healthcare Conference

May 26, 2026 10:20:04 am

SeekingAlpha

Small-cap healthcare stocks ranked by quant ratings after earnings season

May 26, 2026 07:30:00 am

Business Wire

Verastem Oncology Appoints Michael P. Bailey to its Board of Directors

May 08, 2026 11:46:43 am

Motley Fool

Verastem (VSTM) Q1 2026 Earnings Transcript

May 08, 2026 07:30:00 am

Business Wire

On World Ovarian Cancer Day, LGSOC Resource Guide Launches to Support People Living with Low-Grade Serous Ovarian Cancer

May 07, 2026 11:43:02 pm

SeekingAlpha

Verastem outlines cash runway into the first half of 2027 while targeting LGSOC self-sustainability in the second half of 2026

May 07, 2026 11:41:18 pm

SeekingAlpha

Verastem, Inc. (VSTM) Q1 2026 Earnings Call Transcript

May 07, 2026 04:08:29 pm

SeekingAlpha

Verastem Non-GAAP EPS of -$0.43 beats by $0.04, revenue of $18.67M misses by $2.72M

May 07, 2026 04:01:00 pm

Business Wire

Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account